Disopyramide.
Distigmine.
Ditazole.
Dobutamine.
Docetaxol.
Dolasetron.
Dopa.
Dopamine.
Doxapram.
Doxepin, when intended for application to the skin. (S5)
Doxorubicin.
Drotecognin.
Econazole, except when intended for application to the skin and when intended for human vaginal use,
specifically for the treatment of recurrent vaginal candidiasis. (S1)
Enilconazole, except when intended for application to the skin. (S1)
Edoxudine.
Edrophonium.
Efavirenz.
Eletriptan.
Emetine, except substances, preparations and mixtures containing less than 0,2 percent of alkaloids,
calculated as emetine.
Encainide.
Enoxacin.
Enrofloxacine.
Entacapone.
Epirubicin. (4-epidoxorubicin)
Ergot alkaloids (natural or synthetic); except preparations and mixtures thereof when intended for the
treatment of migraine. (S2)
Esomeprazole.
Estramustine.
Etidronate.
Etiproston.
Ethoglucid.
Etofamide.
Etoposide.
Famciclovir.
Famotidine, except when intended for the short term symptomatic relief of heartburn caused by excess
acid, where the maximum dose is 10 milligrams, the maximum daily dose (per 24 hours) is 20 milligrams
and the maximum treatment period is 2 weeks. (S2)
Fazadinium.
Febantel, except when intended and registered as an anthelmintic in terms of the provisions of the
Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947.
Fenchlorphos.
Fenoterol, when intended for the prevention or delay of labour and preparations thereof for injection.
(S2, S3)
Fenticonazole.
Fertirelin.
Filgrastim.
Finasteride.
Flecainide.
Flosequinan.
Fluconazole.
Flucytosine.
Fludarabine.
Flugestone.
Flunisolide.
Fluorides; except oral medicinal preparations and mixtures thereof containing 0,25 milligrams or more of
fluorine as fluoride per recommended daily dose, unless listed in another Schedule. (S1)
5-fluorouracil.
Flurbiprofen, when intended for ophthalmic use. (S1, S2, S3)
Flutamide.
Fluvastatin.
Fondaparinux.
Fotemustine.
Ftorafur.
Furazolidone.
Galatamine.